- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Canine VLP-1 antibody and antigen (recombinant protein)
Diagnostic anti-Canine VLP-1 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-CAN-VLP-1-Ag01 | Canine VLP-1 | $3090.00 |
| GMP-CAN-VLP-1-Ab01 | Anti-Canine VLP-1 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-VLP-1-Ab02 | Anti-Canine VLP-1 mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-VLP-1-Ab03 | Anti-Canine VLP-1 human monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-VLP-1-Ab04 | Anti-Canine VLP-1 human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-CAN-VLP-1-Ag01 |
| Product Name | Canine VLP-1 |
| Target/Biomarker | Canine VLP-1 |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Canine VLP-1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of animal Dog/Canine with Alzheimer Disease(AD). |
| Tag | His | Reconized/Reactive Specics | Canine VLP-1 |
| Product description | Recombinant Canine VLP-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-VLP-1-Ab01,GMP-CAN-VLP-1-Ab02 |
| Target/Biomarker | Canine VLP-1 |
| Product Name | Anti-Canine VLP-1 mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Canine VLP-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VLP-1 antibodies in Canine VLP-1 level test of animal Dog/Canine with Alzheimer Disease(AD). |
| Product description | Anti-Canine VLP-1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VLP-1 antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-VLP-1-Ab03,GMP-CAN-VLP-1-Ab04 |
| Target/Biomarker | Canine VLP-1 |
| Product Name | Anti-Canine VLP-1 human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Canine VLP-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine VLP-1 antibodies in Canine VLP-1 level test of animal Dog/Canine with Alzheimer Disease(AD). |
| Product description | Anti-Canine VLP-1 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Canine Vaccinia-Like Particles-1 (VLP-1) stands as a remarkable biomarker, emblematic of the intricate tapestry of the canine immune system. At its core, VLP-1 is a unique molecular structure, reminiscent of viral particles, yet devoid of the genetic material necessary for viral replication. It primarily comprises protein subunits, enveloping canine DNA fragments within its core.
VLP-1's emergence on the immunological stage is characterized by its role as an immune system sentinel. When dogs encounter pathogens or undergo vaccination, their immune response swings into action. As part of this orchestrated defense, VLP-1 is synthesized and released by immune cells. Its presence acts as a clarion call, signaling the activation of the immune system, particularly in response to viral antigens.
It is crucial to emphasize that VLP-1 is not a pathogenic entity; instead, it serves as an amplification mechanism for the canine immune response. Its virus-like structure triggers a robust immunological reaction, priming the immune defenses to recognize and combat actual viral invaders with enhanced precision and potency. This process underpins the foundation of effective immune responses in dogs.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
